FLEXION THERAPEUTICS INC - COM (FLXN)

CUSIP: 33938J106

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Equity / COM
Total 13F shares
18,828,110
Share change
+5,313,405
Total reported value
$281,765,448
Put/Call ratio
242%
Price per share
$14.96
Number of holders
81
Value change
+$82,507,085
Number of buys
62
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 33938J106?
CUSIP 33938J106 identifies FLXN - FLEXION THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FLEXION THERAPEUTICS INC - COM (FLXN) as of Q2 2016

As of 30 Jun 2016, FLEXION THERAPEUTICS INC - COM (FLXN) was held by 81 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,828,110 shares. The largest 10 holders included GILDER GAGNON HOWE & CO LLC, Capital World Investors, Bank of New York Mellon Corp, KINGDON CAPITAL MANAGEMENT, L.L.C., Novo A/S, DRIEHAUS CAPITAL MANAGEMENT LLC, WELLS FARGO & COMPANY/MN, WASATCH ADVISORS INC, BlackRock Fund Advisors, and TPG Group Holdings (SBS) Advisors, Inc.. This page lists 81 institutional shareholders reporting positions in this security for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.